IRIS
BOLIGNANO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.016
AS - Asia 3.013
EU - Europa 1.210
SA - Sud America 680
AF - Africa 97
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 9.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.807
SG - Singapore 1.348
CN - Cina 651
BR - Brasile 540
IT - Italia 534
VN - Vietnam 317
IN - India 281
CA - Canada 150
SE - Svezia 145
DE - Germania 144
HK - Hong Kong 136
BD - Bangladesh 104
GB - Regno Unito 91
FI - Finlandia 63
AR - Argentina 55
NL - Olanda 42
MX - Messico 34
RU - Federazione Russa 28
RO - Romania 27
EC - Ecuador 26
ID - Indonesia 26
FR - Francia 25
ES - Italia 23
IQ - Iraq 22
PL - Polonia 22
ZA - Sudafrica 20
JP - Giappone 19
UA - Ucraina 18
CL - Cile 17
EG - Egitto 16
CO - Colombia 14
MA - Marocco 13
PK - Pakistan 13
TR - Turchia 13
IR - Iran 12
VE - Venezuela 11
AT - Austria 10
TN - Tunisia 10
UZ - Uzbekistan 9
KE - Kenya 8
PY - Paraguay 8
AU - Australia 7
JO - Giordania 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
IL - Israele 6
SN - Senegal 6
TW - Taiwan 6
PE - Perù 5
TH - Thailandia 5
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
NG - Nigeria 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KR - Corea 2
LB - Libano 2
ML - Mali 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
SI - Slovenia 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 9.015
Salva come PNG Salva come JPEG
Città #
San Jose 766
Singapore 466
Dallas 381
Ashburn 357
Santa Clara 276
Bengaluru 222
Hefei 222
Chandler 212
Milan 192
Lawrence 171
Princeton 171
Hong Kong 134
Ho Chi Minh City 122
Wilmington 117
Beijing 116
Ottawa 106
Munich 102
Council Bluffs 101
Los Angeles 63
Hanoi 59
São Paulo 56
Boardman 54
London 42
Des Moines 38
Turku 38
Chicago 35
New York 35
Rome 29
Helsinki 25
Naples 20
Rio de Janeiro 20
Warsaw 19
Amsterdam 17
Boston 17
Mexico City 17
Da Nang 16
Orem 16
Tokyo 16
Brooklyn 15
Chennai 15
San Francisco 15
The Dalles 15
Bari 14
Brasília 14
Catanzaro 13
Guayaquil 13
Montreal 13
Norwalk 13
Redmond 13
Columbus 12
Johannesburg 12
Biên Hòa 11
Haiphong 11
Timisoara 11
Crotone 10
Guangzhou 10
Guarulhos 10
New Delhi 10
Phoenix 10
Seattle 10
Stockholm 10
Atlanta 9
Jakarta 9
Manchester 9
Palermo 9
Pune 9
Baghdad 8
Charlotte 8
Florence 8
Hải Dương 8
Ninh Bình 8
Shibin al Kawm 8
Tashkent 8
Ankara 7
Erbil 7
Nairobi 7
Redwood City 7
Santo André 7
Thái Bình 7
Toronto 7
Ann Arbor 6
Asunción 6
Buenos Aires 6
Campinas 6
Catania 6
Cosenza 6
Dakar 6
Goiânia 6
Osasco 6
Quito 6
Salvador 6
São Bernardo do Campo 6
Tunis 6
Washington 6
Amman 5
Belo Horizonte 5
Bologna 5
Bình Dương 5
Curitiba 5
Denver 5
Totale 5.410
Salva come PNG Salva come JPEG
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 128
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 119
Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy 111
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 88
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 88
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 83
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 81
A brief "update" on renal effects of caffeine 80
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. 79
Erratum: Exercise in patients on dialysis: A multicenter, randomized clinical trial (Journal of the American Society of Nephrology (2017) 28 (1259–1268) DOI: 10.1681/ASN.2016030378) 78
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 77
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 73
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 71
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 70
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 69
[AVP: a new target in the treatment of chronic kidney disease?] 69
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 69
Renal denervation for resistant hypertension 68
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 68
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 66
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 65
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 64
Hyperkalemia in CKD: an overview of available therapeutic strategies 64
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 63
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 63
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 62
Aldosterone antagonists for preventing the progression of chronic kidney disease 62
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 61
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 61
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide 61
Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment 60
[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology] 60
Effects of weight loss on renal function in obese CKD patients: A systematic review 59
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 59
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 58
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 58
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 58
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 57
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 57
Development of a Wearable Device for Arteriovenous Fistula Monitoring 56
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 56
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 55
Erythropoietin and its lost receptor 55
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care] 55
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 55
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all 54
Aquaretic agents: What's beyond the treatment of hyponatremia? 53
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 53
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools 52
Aquaretic-induced apoptosis: A cure or a curse? 52
Glitazones in chronic kidney disease: Potential and concerns 52
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 52
Childhood Obesity: Insight into Kidney Involvement 51
Acute cardiovascular complications of hemodialysis 51
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 50
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 49
Dialysis and the Elderly: An Underestimated Problem 49
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 49
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 49
Study designs adopted in epidemiology of chronic diseases 49
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 48
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 48
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 48
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial 48
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis 48
[Erythropoietin: pleiotropic actions] 48
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 48
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization 47
Genomic damage in endothelial progenitor cells from uremic patients 47
[The future of the European nephrology belongs to the young: the Young Nephrologists' Platform] 47
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 47
Immunosuppressive Therapy, Puberty and Growth Outcomes in Pediatric Kidney Transplant Recipients: A Pragmatic Review 46
Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease 45
Malnutrition in the elderly patient on dialysis 45
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 45
Caffeine and the kidney: What evidence right now? 45
Neutrophil Gelatinase-associated Lipocalin in the Cardio–Renal Axis – Pathogenic Factor or Just a Risk Biomarker? 45
Oxidative stress and kidney function: a brief update 45
The aging kidney revisited: A systematic review 45
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. 44
Baroreflex stimulation for treating resistant hypertension: Ready for the prime-time? 44
Study designs adopted in epidemiology of chronic diseases 44
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients 43
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 43
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 43
Physical excercise programs in CKD: lights, shades and perspectives: a position paper of the “Physical Exercise in CKD Study Group” of the Italian Society of Nephrology 43
Good-quality research in rare diseases: trials and tribulations 43
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 43
Smoking habit as a risk amplifier in chronic kidney disease patients 43
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study 42
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R) 42
[TNF-alpha receptors (TNFRS): the biomarkers of progressive diabetic nephropathy we were waiting for?] 42
A new therapy for kidney injury: regeneration 42
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases 42
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 42
Neurobiological model and quality of life in discovering personality of the uremic patient 41
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life 41
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 41
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 41
Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease 40
Totale 5.658
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022452 17 1 3 86 59 5 18 120 29 25 85 4
2022/2023869 344 99 17 38 54 43 13 55 100 28 57 21
2023/2024533 74 41 43 39 42 89 25 47 25 45 28 35
2024/20252.115 312 70 54 132 145 349 49 63 240 62 231 408
2025/20264.972 252 582 627 775 480 167 514 248 666 384 218 59
Totale 9.303